$MCK

The Medical Records Access Fairness Act of 2026 mandates standardized, interoperable electronic health record (EHR) access, creating a significant market for health IT solutions and data management. This bill directly benefits companies providing EHR systems, data integration, and secure cloud storage, while increasing compliance costs for healthcare providers.

This bill directly targets the availability of mifepristone, a key drug in reproductive healthcare. Its passage would eliminate a significant market for pharmaceutical companies and could increase demand for other healthcare services.

McKesson Corporation ($MCK) has secured a $204 million contract from the CDC for centralized vaccine distribution, reinforcing its critical role in public health infrastructure. This award represents a meaningful, albeit not transformative, revenue stream for the company, aligning with ongoing legislative support for healthcare programs.

The BUST FENTANYL Act, S860, targets the fentanyl crisis through enhanced detection and interdiction. This bill increases demand for drug screening technologies, laboratory services, and pharmaceutical countermeasures, directly benefiting companies in these sectors.